1. LIFESCI ADVISORS LIFESCI ADVISORS Equity Research Page 1 June 10, 2010 Initiation of Coverage We are initiating coverage on Rockwell Medical. Our research describes Rockwell’s…

A RANDOMIZED, OPEN-LABEL STUDY TO OPENCOMPARE TWO DIFFERENT SIROLIMUS (SRL) ( ) REGIMENS WITH TACROLIMUS (TAC) AND MYCOPHENOLATE MOFETIL (MMF) IN DE NOVO RENAL ALLOGRAFT…

Name of presentation JOURNAL CLUB Dr.Yassin Alsaleh 1 Introduction Hypophosphatasia is a rare, and sometimes fatal metabolic bone disease. characterized by low serum alkaline-phosphatase…

1. PEMBROLIZUMAB “Treatment of melanoma has never been this promising” By: Patwant Dhillon 2. METASTATIC MELANOMA •  10-year survival rate less than 10% •  Single-agent…

Slide 1 www.uracyst.co.uk Uracyst A summary of the rationale and clinical evidence Abbreviated Prescribing Information can be found on the last slide of this presentation.…

Slide 1 Cancer pain: Neuropathic pain and BTcP Sebastiano Mercadante, MD Director Anesthesia and Intensive Care Unit Pain Relief and Palliative Care Unit La Maddalena Cancer…

Slide 1 Lap-Band Surgery for Adolescents NYU Medical Center Program for Surgical Weight Loss George Fielding, MD Associate Professor of Surgery Evan P. Nadler, MD Assistant…

Slide 1 1 Endocrinologic and Metabolic Drugs Advisory Committee Meeting January 15, 2003 Sponsor Presentation Aldurazyme ® (laronidase) Slide 2 2 Introduction Meeting subject…

Slide 1 ARBITER 6-HALTS HDL And LDL Treatment Strategies Extended-Release Niacin vs. Ezetimibe Added to Chronic Statin Therapy and Carotid Intima–Media Thickness Final…

Slide 1 Slide 2 Isotonix Coenzyme Q10 Prepared by Newman Doo Slide 3 Introduction w The purpose of this slide show is to reveal the wonder of Coenzyme Q10. Slide 4 Topics…